It seems quite obvious that we will need to complete at least another phase 2 trial with a larger sample size.
Looking at the other horse in this race (Abivax) a European company now going into a phase 2b trial and who has completed 3x 2a trials I believe. Interestingly announced a similar result only 4 months before Biotron did last year!
Has this now become a 2 horse race?
It seems quite obvious that we will need to complete at least...
-
- There are more pages in this discussion • 11,974 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
